From DCAT Value Chain Insights (VCI)
Sanofi has appointed Hugo Fry as general manager for the UK and general manager Sanofi Pasteur for the UK and Ireland. In addition, the company has appointed Dr. Hubert Bland as UK medical chair and medical head of diabetes and cardiovascular for the UK and Ireland.
Mr. Fry has over 20 years of experience in the pharmaceutical industry and has held various global and regional management, commercial, and strategic roles. Prior to assuming the general manager role, Mr. Fry was the chief marketing officer for Sanofi Pasteur MSD, leading the commercial effort for the European vaccine joint venture.
Dr. Bland joins Sanofi from TMC Pharma Services, a Hampshire, UK-based consulting firm, where he held the role of vice president of medical since 2013. Prior to this, he held medical leadership positions at Pfizer, Boehringer-Ingelheim, Linde, and the University of Surrey’s Clinical Research Centre.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription